Therapie der Aortenklappenstenose: wann interventionell, wann operativ?

Abstract

The mainstay for the current treatment of severe aortic stenosis includes surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI). In patients with high operative risk TAVI is established as first line therapy. New data on intermediate and low risk groups demonstrate at least non-inferiority of TAVI against SAVR, and in the near future a consistently rising number of transcatheter procedures may be anticipated. The purpose of this review is to outline the decision making process, hence to illustrate the diagnostic algorithm and to provide criteria for a differentiated approach against the background of recent data.

Eine hochgradige Aortenklappenstenose hat unbehandelt eine schlechte Prognose. Ob mit konventionellem Aortenklappenersatz oder Transkatheter-Aortenklappenimplantation therapiert werden sollte, hängt von der individuellen Situation des Patienten sowie dessen OP-Risiko ab. Der Beitrag fasst erforderliche Diagnostiken und Kriterien zur Therapieentscheidung vor dem Hintergrund aktuelle Daten zusammen.

Schlüsselwörter

Aortenklappenstenose - TAVI - Aortenklappenersatz - Heart Team

Key words

aortic stenosis - TAVI - surgical aortic valve replacement - heart team

• Literatur

• 1 Bach DS. Cimino N. Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol 2007; 50: 2018-2019
• 2 Adams DH. Popma JJ. Reardon MJ. et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014; 370: 1790-1798
• 3 Kapadia SR. Leon MB. Makkar RR. et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2485-2491
• 4 Hamm CW. Mollmann H. Holzhey D. et al. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J 2014; 35: 1588-1598
• 5 Walther T. Hamm CW. Schuler G. et al. Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. J Am Coll Cardiol 2015; 65: 2173-2180
• 6 Leon MB. Smith CR. Mack MJ. et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016; 374: 1609-1620
• 7 Thourani VH. Kodali S. Makkar RR. et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients. Lancet 2016; 387: 2218-2225
• 8 Siontis GC. Praz F. Pilgrim T. et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J 2016;
• 9 Vahanian A. Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S. et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-2496
• 10 Pibarot P. Dumesnil JG. Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. J Am Coll Cardiol 2012; 60: 1845-1853
• 11 Pibarot P. Clavel MA. Management of paradoxical low-flow, low-gradient aortic stenosis: need for an integrated approach, including assessment of symptoms, hypertension, and stenosis severity. J Am Coll Cardiol 2015; 65: 67-71
• 12 Achenbach S. Delgado V. Hausleiter J. et al. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr 2012; 6: 366-380
• 13 Khawaja MZ. Wang D. Pocock S. et al. The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial. Trials 2014; 15: 300
• 14 Smith CR. Leon MB. Mack MJ. et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198
• 15 Thyregod HG. Steinbruchel DA. Ihlemann N. et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol 2015; 65: 2184-2194
• 16 Mollmann H. Bestehorn K. Bestehorn M. et al. In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 2016; 105: 553-559
• 17 Kuck KH. Eggebrecht H. Elsässer A. et al. Qualitätskriterien zur Durchführung der kathetergestützten Aortklappenimplantation (TAVI) – Aktualisierung des Positionspapiers der Deutschen Gesellschaft für Kardiologie. Kardiologie 2016; 10: 282-300
• 18 Piazza N. Wenaweser P. van Gameren M. et al. Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system – a Bern-Rotterdam Study. Am Heart J 2010; 159: 323-329
• 19 Toggweiler S. Humphries KH. Lee M. et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol 2013; 61: 413-419
• 20 Blumenstein J. Van Linden A. Kim WK. et al. Early SAPIEN transcatheter heart valve dysfunction due to tissue ingrowth in an octogenarian. Clin Res Cardiol 2013; 102: 237-240
• 21 Piazza N. Lange R. Martucci G. et al. Patient selection for transcatheter aortic valve implantation: patient risk profile and anatomical selection criteria. Arch Cardiovasc Dis 2012; 105: 165-173